Filing Details
- Accession Number:
- 0001127602-17-032117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-14 19:27:10
- Reporting Period:
- 2017-11-13
- Accepted Time:
- 2017-11-14 19:27:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1541946 | E Sean Harper | One Amgen Center Drive Thousand Oaks CA 91320-1799 | Evp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-11-13 | 1,525 | $171.58 | 57,631 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
Billionaire Hedge Funds
